About Bukwang Pharmaceutical
Bukwang Pharmaceutical is a company based in South Korea. It operates as a HealthTech, and Direct-to-Consumer (D2C). Bukwang Pharmaceutical has raised $5.2 million across 1 funding round from investors including TVM Capital Life Science. Bukwang Pharmaceutical has completed 1 acquisition, including Korea Union Pharmaceuticals. Bukwang Pharmaceutical offers products and services including Lurasidone, JM-010, SOL-804, and Legadex.
- Headquarter South Korea
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Bukwang Pharm Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.2 M (USD)
in 1 rounds
-
Latest Funding Round
$5.2 M (USD), Series A
Mar 29, 2017
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bukwang Pharmaceutical
Bukwang Pharmaceutical offers a comprehensive portfolio of products and services, including Lurasidone, JM-010, SOL-804, and Legadex. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for treating schizophrenia and bipolar depression effectively.
Developed for treating dyskinesia in Parkinson’s disease patients.
Designed for metastatic castration-resistant prostate cancer treatment.
Formulated as a liver disease treatment compound drug.
Unlock access to complete
Unlock access to complete
Funding Insights of Bukwang Pharmaceutical
Bukwang Pharmaceutical has successfully raised a total of $5.2M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.2 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $5.2M
-
First Round
First Round
(29 Mar 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Series A - Bukwang Pharmaceutical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bukwang Pharmaceutical
Bukwang Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include TVM Capital Life Science. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Science focused early stage VC firm investing in Europe, Canada, the USA and Asia
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bukwang Pharmaceutical
Bukwang Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Korea Union Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Utility industry construction, inspection, and maintenance services are provided.
|
1956 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bukwang Pharmaceutical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bukwang Pharmaceutical Comparisons
Competitors of Bukwang Pharmaceutical
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bukwang Pharmaceutical
Frequently Asked Questions about Bukwang Pharmaceutical
Where is Bukwang Pharmaceutical located?
Bukwang Pharmaceutical is headquartered in South Korea.
Is Bukwang Pharmaceutical a funded company?
Bukwang Pharmaceutical is a funded company, having raised a total of $5.2M across 1 funding round to date. The company's 1st funding round was a Series A of $5.2M, raised on Mar 29, 2017.
What does Bukwang Pharmaceutical do?
Bukwang Pharmaceutical is involved in the research, development, and production of pharmaceutical products, including prescription medicines, over-the-counter drugs, and health supplements. The company operates in the healthcare sector, focusing on innovative drug development for conditions such as schizophrenia, Parkinsons disease, and prostate cancer. Solutions are provided through a robust pipeline and open innovation strategies, aiming for global expansion as a leading pharmaceutical entity. Emphasis is placed on sustainability and ethical governance to ensure a healthier future.
What products or services does Bukwang Pharmaceutical offer?
Bukwang Pharmaceutical offers Lurasidone, JM-010, SOL-804, and Legadex.
How many acquisitions has Bukwang Pharmaceutical made?
Bukwang Pharmaceutical has made 1 acquisition, including Korea Union Pharmaceuticals.
Who are Bukwang Pharmaceutical's investors?
Bukwang Pharmaceutical has 1 investor. Key investors include TVM Capital Life Science.